All,
I was asked by the meeting organizers to let the CCP4 community know
about the Residential School on Medicinal Chemistry and Biology in Drug
Discovery. See below for information about the course and contact
information.
Sincerely,
Corey
--------------------------------------
Residential School on Medicinal Chemistry and Biology in Drug Discovery
(ResMed): A Comprehensive One-Week Course
(http://www.drew.edu/resmed/)
The 28th Annual ResMed: Residential School on Medicinal Chemistry and Biology
in Drug Discovery will be held on June 8 - June 13, 2014 at Drew University in
Madison, NJ and is co-sponsored by the ACS MEDI Division.
ResMed is a week-long graduate level course organized to provide an accelerated
program for chemists, biologists and other industrial and academic scientists
who wish to broaden their knowledge of drug discovery and development. The
School's aim is to concentrate on the fundamentals that are useful in drug
discovery spanning initial target validation through clinical development. The
program provides ample opportunity for discussions with distinguished faculty
from industry and academia.
The purpose of the School is to provide a strong background in the principles
of drug discovery and development to enhance collaborative drug discovery
programs. Previous attendees with backgrounds in macromolecular crystallography
have found the course of great value in their research projects.
Information regarding ResMed can be accessed on our website:
www.drew.edu/resmed including our program and application.
Please join us in our 28th year. We look forward to seeing you.
Co-organizers,
William J. Greenlee, Ph.D
Vincent P. Gullo, Ph.D.
Ronald J. Doll, Ph.D.
Notice: This e-mail message, together with any attachments, contains
information of Merck & Co., Inc. (One Merck Drive, Whitehouse Station,
New Jersey, USA 08889), and/or its affiliates Direct contact information
for affiliates is available at
http://www.merck.com/contact/contacts.html) that may be confidential,
proprietary copyrighted and/or legally privileged. It is intended solely
for the use of the individual or entity named on this message. If you are
not the intended recipient, and have received this message in error,
please notify us immediately by reply e-mail and then delete it from
your system.
